{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:39:16Z","timestamp":1790811556692,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.biopha.2021.111624","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T06:44:00Z","timestamp":1619419440000},"page":"111624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction"],"prefix":"10.1016","volume":"139","author":[{"given":"Ahmed S.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Mona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona A.","family":"Abdel\u2011Kareem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha A.","family":"Elsisy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2021.111624_bib1","first-page":"84","article-title":"Acute kidney injury [published correction appears]","volume":"167","author":"Levey","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.111624_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cnur.2018.07.001","article-title":"Acute kidney injury","volume":"53","author":"Farrar","year":"2018","journal-title":"Nurs. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.biopha.2021.111624_bib3","first-page":"373","article-title":"Biomarkers of renal recovery after acute kidney injury. Biomarcadores de recupera\u00e7\u00e3o renal ap\u00f3s les\u00e3o renal aguda","volume":"29","author":"Gai\u00e3o","year":"2017","journal-title":"Rev. Bras. Intensiv."},{"key":"10.1016\/j.biopha.2021.111624_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000484968","article-title":"Pediatric acute kidney injury","volume":"193","author":"Fragasso","year":"2018","journal-title":"Contrib. Nephrol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111624_bib5","first-page":"580","article-title":"Acute kidney injury in pregnancy","volume":"25","author":"Vijayan","year":"2019","journal-title":"Curr. Opin. Crit. Care"},{"issue":"4","key":"10.1016\/j.biopha.2021.111624_bib6","first-page":"376","article-title":"Protective effects of curcumin on diabetic nephropathy via attenuation of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) expression and alleviation of oxidative stress in rats with type 1 diabetes","volume":"22","author":"Ghasemi","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.biopha.2021.111624_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.acc.2018.10.005","article-title":"Novel glomerular filtration markers","volume":"88","author":"George","year":"2019","journal-title":"Adv. Clin. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2021.111624_bib8","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1159\/000492407","article-title":"Prognostic value of urinary calprotectin, NGAL and KIM-1 in chronic kidney disease","volume":"43","author":"Seibert","year":"2018","journal-title":"Kidney Blood Press. Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.111624_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/1535370217745302","article-title":"Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy","volume":"243","author":"George","year":"2018","journal-title":"Exp. Biol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2021.111624_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00431-017-2907-y","article-title":"Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury","volume":"176","author":"Westhoff","year":"2017","journal-title":"Eur. J. Pedia"},{"issue":"1","key":"10.1016\/j.biopha.2021.111624_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000481179","article-title":"Urinary kidney injury molecule-1 but not urinary neutrophil gelatinase associated lipocalin is increased after short maximal exercise","volume":"138","author":"Wo\u0142yniec","year":"2018","journal-title":"Nephron"},{"issue":"11","key":"10.1016\/j.biopha.2021.111624_bib12","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1177\/0961203318788167","article-title":"Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis","volume":"27","author":"Ding","year":"2018","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.biopha.2021.111624_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ejhf.1432","article-title":"DAPA-HF Committees and I. A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)","volume":"21","author":"McMurray","year":"2019","journal-title":"Eur. J. Heart Fail"},{"issue":"11","key":"10.1016\/j.biopha.2021.111624_bib14","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.amjcard.2019.08.038","article-title":"Sodium glucose Co-transporter 2 inhibitors and heart failure","volume":"124","author":"Ghosh","year":"2019","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111624_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022577","article-title":"Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis","volume":"9","author":"Donnan","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.biopha.2021.111624_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/dom.13101","article-title":"Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: a meta-analysis of randomized controlled trials","volume":"20","author":"Zhao","year":"2018","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2021.111624_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/ijem.IJEM_160_17","article-title":"Sodium glucose Co-transporter-2 inhibitor: benefits beyond glycemic control","volume":"23","author":"Baruah","year":"2019","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2021.111624_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/2047487318755531","article-title":"Sodium-glucose co-transporter 2 inhibitors and cardiovascular outcomes: a systematic review and meta-analysis","volume":"25","author":"Usman","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2021.111624_bib19","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.amjcard.2019.10.027","article-title":"Renal effects of sodium-glucose co-transporter inhibitors","volume":"124","author":"Thomson","year":"2019","journal-title":"Am. J. Cardiol."},{"issue":"21","key":"10.1016\/j.biopha.2021.111624_bib20","article-title":"Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: association with a slight increase in high-density lipoprotein cholesterol","volume":"S0167\u20135273","author":"Jojima","year":"2021","journal-title":"Int J. Cardiol."},{"key":"10.1016\/j.biopha.2021.111624_bib21","article-title":"Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2021.111624_bib22","first-page":"54100","article-title":"Myocardial infarction in neonatal mice, A model of cardiac regeneration","volume":"111","author":"Blom","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"4","key":"10.1016\/j.biopha.2021.111624_bib23","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s11250-019-02162-z","article-title":"Impact of dietary supplementation with Echinacea purpurea on growth performance, immunological, biochemical, and pathological findings in broiler chickens infected by pathogenic E. coli","volume":"52","author":"Hashem","year":"2020","journal-title":"Trop. Anim. Health Prod."},{"key":"10.1016\/j.biopha.2021.111624_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4939-1050-2_3","article-title":"Tissue processing and hematoxylin and eosin staining","volume":"1180","author":"Feldman","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2021.111624_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-7163-3_14","article-title":"Periodic acid-schiff staining with diastase","volume":"1639","author":"Fu","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2021.111624_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-4939-7172-5_5","article-title":"Principles and methods of immunohistochemistry","volume":"1641","author":"Ramos-Vara","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111624_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12867-018-0103-x","article-title":"Recommendations for mRNA analysis of micro-dissected glomerular tufts from paraffin-embedded human kidney biopsy samples","volume":"19","author":"Bockmeyer","year":"2018","journal-title":"BMC Mol. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111624_bib28","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1152\/ajpheart.00205.2017","article-title":"Diabetes increases the susceptibility to acute kidney injury after myocardial infarction through augmented activation of renal Toll-like receptors in rats","volume":"313","author":"Ohno","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111624_bib29","first-page":"191","article-title":"Tofogliflozin, a highly selective inhibitor of SGLT2 blocks proinflammatory and proapoptotic effects of glucose overload on proximal tubular cells partly by suppressing oxidative stress generation","volume":"48","author":"Ishibashi","year":"2016","journal-title":"Horm. Metab. Res."},{"issue":"12","key":"10.1016\/j.biopha.2021.111624_bib30","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s00125-014-3396-4","article-title":"Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration","volume":"57","author":"\u0160krti\u0107","year":"2014","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.biopha.2021.111624_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-018-0797-6","article-title":"Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus","volume":"17","author":"Lunder","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111624_bib32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.biopha.2021.111624_bib33","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3390\/jcm8111814","article-title":"The SGLT2 inhibitor empagliflozin ameliorates the inflammatory profile in Type 2 diabetic patients and promotes an antioxidant response in leukocytes","volume":"8","author":"Iannantuoni","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2021.111624_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13098-020-0515-x","article-title":"Enhancement of the serum chloride concentration by administration of sodium-glucose cotransporter-2 inhibitor and its mechanisms and clinical significance in type 2 diabetic patients: a pilot study","volume":"12","author":"Kataoka","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.biopha.2021.111624_bib35","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ejhf.1473","article-title":"Sodium\u2013glucose co\u2010transporter 2 inhibition with empagliflozin improves cardiac function in non\u2010diabetic rats with left ventricular dysfunction after myocardial infarction","volume":"21","author":"Yurista","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2021.111624_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11010-020-03686-x","article-title":"Inhibition of tumor necrosis factor-\u03b1 enhanced the antifibrotic effect of empagliflozin in an animal model with renal insulin resistance","volume":"466","author":"Mohamed","year":"2020","journal-title":"Mol. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.biopha.2021.111624_bib37","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2174\/1389203717666160909125004","article-title":"The update of NGAL in acute kidney injury","volume":"18","author":"Shang","year":"2017","journal-title":"Curr. Protein Pept. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111624_bib38","first-page":"384","article-title":"Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis","volume":"22","author":"Ashrafi Jigheh","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111624_bib39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/PEC.0000000000000886","article-title":"Urine KIM-1 as a potential biomarker of acute renal injury after circulatory collapse in children","volume":"35","author":"Assadi","year":"2019","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.biopha.2021.111624_bib40","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1124\/jpet.118.253666","article-title":"Empagliflozin, an SGLT2 inhibitor, reduced the mortality rate after acute myocardial infarction with modification of cardiac metabolomes and antioxidants in diabetic rats","volume":"368","author":"Oshima","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2021.111624_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006277","article-title":"Empagliflozin blunts worsening cardiac dysfunction associated with reduced NLRP3 (nucleotide-binding domain-like receptor protein 3) inflammasome activation in heart failure","volume":"13","author":"Byrne","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.biopha.2021.111624_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10787-020-00732-4","article-title":"Empagliflozin suppresses inflammation and protects against acute septic renal injury","volume":"29","author":"Maayah","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2021.111624_bib43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.biochi.2018.12.014","article-title":"Amelioration of sepsis-induced acute kidney injury through inhibition of inflammatory cytokines and oxidative stress in dendritic cells and neutrophils respectively in mice: role of spleen tyrosine kinase signaling","volume":"158","author":"Al-Harbi","year":"2019","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.biopha.2021.111624_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/labinvest.2017.120","article-title":"NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation","volume":"98","author":"Meng","year":"2018","journal-title":"Lab. Investig."},{"issue":"3","key":"10.1016\/j.biopha.2021.111624_bib45","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1002\/jcb.27722","article-title":"TLR2 protects cisplatin-induced acute kidney injury associated with autophagy via PI3K\/Akt signaling pathway","volume":"120","author":"Shen","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2021.111624_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000480340","article-title":"Involvement of S100A8\/A9-TLR4-NLRP3 inflammasome pathway in contrast-induced acute kidney injury","volume":"43","author":"Tan","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2021.111624_bib47","doi-asserted-by":"crossref","first-page":"26954","DOI":"10.1038\/srep26954","article-title":"Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2021.111624_bib48","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2016070761","article-title":"Mitochondria protection after acute ischemia prevents prolonged upregulation of IL-1\u03b2 and IL-18 and arrests CKD","volume":"28","author":"Szeto","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"39","key":"10.1016\/j.biopha.2021.111624_bib49","doi-asserted-by":"crossref","first-page":"12570","DOI":"10.1097\/MD.0000000000012570","article-title":"Comparison of urine neutrophil gelatinase-associated lipocalin and interleukin-18 in prediction of acute kidney injury in adults","volume":"97","author":"Gan","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2021.111624_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/967826","article-title":"Pathophysiology of cisplatin-induced acute kidney injury","volume":"2014","author":"Ozkok","year":"2014","journal-title":"Biomed. Res. Int."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221004091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221004091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:28:36Z","timestamp":1760099316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221004091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":50,"alternative-id":["S0753332221004091"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111624","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111624"}}